| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/24/2002 | EP1224219A1 Beta-defensins |
| 07/24/2002 | EP1224218A1 Dna encoding human alpha1g-c t-type calcium channel |
| 07/24/2002 | EP1224216A1 Mage-a1 peptides presented by hla class ii molecules |
| 07/24/2002 | EP1224209A1 10 human secreted proteins |
| 07/24/2002 | EP1224208A1 Human inwardly rectifying potassium channel subunit |
| 07/24/2002 | EP1224201A1 32 human secreted proteins |
| 07/24/2002 | EP1224200A1 Tissue plasminogen activator-like protease |
| 07/24/2002 | EP1224199A1 Transgenic mice containing trp gene disruptions |
| 07/24/2002 | EP1223973A2 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization |
| 07/24/2002 | EP1223970A1 Short segments of dap-kinase |
| 07/24/2002 | EP1223963A2 T-cells and molecules involved in immune regulation |
| 07/24/2002 | EP1223956A1 Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 07/24/2002 | EP1223953A1 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 07/24/2002 | EP1223946A1 Human neuropeptide receptor |
| 07/24/2002 | EP0793714B1 Use of stem cell factor and soluble interleukin-6 receptor for the ex vivo expansion of hematopoietic multipotential cells |
| 07/24/2002 | EP0719340B1 Cloned glutamic acid decarboxylase |
| 07/24/2002 | EP0674497B1 Microporous macrocapsules |
| 07/24/2002 | EP0664832B1 Remyelination using neural stem cells |
| 07/24/2002 | EP0589898B1 Production of polyhydroxyalkanoate in plants |
| 07/24/2002 | EP0579640B1 Glial mitogenic factors, their preparation and use |
| 07/24/2002 | CN1360638A Recombinant protein production in human cell using sequences encoding adenovirus E1 protein |
| 07/24/2002 | CN1360634A Herbicide resistant plants |
| 07/24/2002 | CN1360633A Fucosyl transferase gene |
| 07/24/2002 | CN1360631A Methods and compositions for preventing formation of aberrant RNA during transcription of plasmid sequence |
| 07/24/2002 | CN1360628A Method for transfer of antigens to dendritic cells |
| 07/24/2002 | CN1360596A Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 07/24/2002 | CN1360595A Immunogenic peptides derived from MAGE and use thereof |
| 07/24/2002 | CN1360466A Construction of rice tolerant to iron deficiency |
| 07/24/2002 | CN1360059A Method for specific detection of tumor cell and its precursor in cervix smear by simultaneously measuring at least two different molecular labels |
| 07/24/2002 | CN1360025A Autoimmune cell for treating tumor and its preparing process |
| 07/24/2002 | CN1088105C Blood-borne mesenchymal cells |
| 07/23/2002 | US6423836 Production and use of human nm23 protein and antibodies therefor |
| 07/23/2002 | US6423790 Tissue replacements |
| 07/23/2002 | US6423693 Growth hormone releasing hormone expression system and methods of use, including use in animals |
| 07/23/2002 | US6423681 Method of inducing formation of kidney epithelia from mesenchymal precursors |
| 07/23/2002 | US6423544 Compositions and methods for producing recombinant virions |
| 07/23/2002 | US6423540 Cell differentiation protein |
| 07/23/2002 | US6423539 Enhancing immunology response |
| 07/23/2002 | US6423529 Composition useful for the early diagnosis of visceral leishmaniasis and a process for preparing the same |
| 07/23/2002 | US6423527 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 07/23/2002 | US6423521 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/23/2002 | US6423520 Regulation of quinolate phosphoribosyl transferase expression |
| 07/23/2002 | US6423508 Polynucleotide sequences of human EDG-1c |
| 07/23/2002 | US6423507 Detecting enzyme inhibitors; obtain protease, incubate with modulator, monitor adjustment in protease activity |
| 07/23/2002 | US6423504 Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof |
| 07/23/2002 | US6423502 Method for screening candidate pesticides using a receptor that binds Bacillus thuringiensis toxin |
| 07/23/2002 | US6423500 Mammalian receptors for interleukin-10 |
| 07/23/2002 | US6423333 Sealing or filling tissue defects using polyfunctional crosslinking agents and protein polymers |
| 07/23/2002 | US6423316 Anticoagulant fusion protein anchored to cell membrane |
| 07/23/2002 | CA2368791A1 Medicament for the protection against thrombotic diseases |
| 07/23/2002 | CA2365997A1 Novel polypeptide |
| 07/23/2002 | CA2261569C Method for mass production of antimicrobial peptide |
| 07/23/2002 | CA2074720C Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 07/23/2002 | CA2072642C Fusion proteins consisting of a ligand binding protein and a stable plasma protein |
| 07/18/2002 | WO2002056027A2 Regulation of neutral development by daedalos |
| 07/18/2002 | WO2002055992A2 Intrinsically fluorescent, self-multimerizing mhc fusion proteins and complexes thereof |
| 07/18/2002 | WO2002055725A2 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production |
| 07/18/2002 | WO2002055720A2 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 07/18/2002 | WO2002055719A2 Expression of foreign genes from plant virus vectors |
| 07/18/2002 | WO2002055716A1 Antibiotics-independent vector for constant high-expression and method for gene expression using the same |
| 07/18/2002 | WO2002055706A2 Asip-related proteins |
| 07/18/2002 | WO2002055705A2 Proteins and nucleic acids encoding same |
| 07/18/2002 | WO2002055704A2 Proteins, polynucleotides encoding them and methods of using the same |
| 07/18/2002 | WO2002055700A2 Human genes and gene expression products isolated from human prostate |
| 07/18/2002 | WO2002055698A2 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 07/18/2002 | WO2002055694A2 Discriminative nucleic acid analysis using clone sequence signatures |
| 07/18/2002 | WO2002055691A1 Gene encoding aip-1/flash promoter and use thereof |
| 07/18/2002 | WO2002055680A2 Morphometric tissue or cell preparation |
| 07/18/2002 | WO2002055679A2 Thermostable lipolytic enzyme variant |
| 07/18/2002 | WO2002055678A1 Extramedullary adipose tissue cells and use thereof for regenerating hematopoietic and muscular tissues |
| 07/18/2002 | WO2002055677A1 Transplantation cell kits for re-myelination in nerve cells |
| 07/18/2002 | WO2002055676A2 Method for processing dendritic cells and for activating macrophages with ru 41740 |
| 07/18/2002 | WO2002055675A1 Ancillary composition for the preparation of committed mature dendritic cells |
| 07/18/2002 | WO2002055658A2 Identification and characterization of an anthocyanin mutant (ant1) in tomato |
| 07/18/2002 | WO2002055651A2 Processes and vectors for plastid transformation |
| 07/18/2002 | WO2002055561A1 Method for surface display of proteins on genetic carriers |
| 07/18/2002 | WO2002055555A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 07/18/2002 | WO2002055547A2 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 07/18/2002 | WO2002055544A2 Fibrin binding polypeptides useful inter alia in medical imaging processes |
| 07/18/2002 | WO2002055532A2 Variant growth hormone molecules conjugated with macromolecular compounds |
| 07/18/2002 | WO2002055109A2 Generation and/or reduction of new lung tissue in an affected lung, by modulation of the wnt-pathway |
| 07/18/2002 | WO2002055108A1 Targeted modification of intracellular compounds |
| 07/18/2002 | WO2002055103A1 Tumor vaccines |
| 07/18/2002 | WO2002055098A2 Latency associated peptide for providing latency to pharmaceutically active proteins |
| 07/18/2002 | WO2002055010A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/18/2002 | WO2002048247A8 Biocompatible, porous material, method for its production and use of the same |
| 07/18/2002 | WO2002044422A8 Method for ultra-high resolution mapping of genes and determination of genetic networks among genes underlying phenotypic traits |
| 07/18/2002 | WO2002029011A3 Use of a composition with antioxidant activity for conditioning stem cells |
| 07/18/2002 | WO2002028414B1 Compositions and methods for wt1 specific immunotherapy |
| 07/18/2002 | WO2002028351A3 Recombinant mucin binding proteins from steptococcus pneumoniae |
| 07/18/2002 | WO2002026116A9 Repair and regeneration of cartilage, collagen and bone remodeling |
| 07/18/2002 | WO2002022776A3 Human coagulation factor vii variants |
| 07/18/2002 | WO2002014482A3 Polyketides and their synthesis |
| 07/18/2002 | WO2002006311A3 Olfactory g-protein coupled receptor |
| 07/18/2002 | WO2002004516A3 Use of the heat shock protein gp96 |
| 07/18/2002 | WO2002002789A3 Compositions and methods for producing recombinant virions |
| 07/18/2002 | WO2002002633A3 Transporters and ion channels |
| 07/18/2002 | WO2002000847A3 Pluripotent embryonic stem (es) cell lines, improved methods for their production, and their use for germ line transmission and for the generation of genetically modified animals |
| 07/18/2002 | WO2001094551A3 Genetically modified t-cells, method for producing them and use thereof |
| 07/18/2002 | WO2001094391A3 Intracellular signaling proteins |